pubmed-article:20061026 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20061026 | lifeskim:mentions | umls-concept:C0023281 | lld:lifeskim |
pubmed-article:20061026 | lifeskim:mentions | umls-concept:C0012984 | lld:lifeskim |
pubmed-article:20061026 | lifeskim:mentions | umls-concept:C0024432 | lld:lifeskim |
pubmed-article:20061026 | lifeskim:mentions | umls-concept:C0042210 | lld:lifeskim |
pubmed-article:20061026 | lifeskim:mentions | umls-concept:C0085732 | lld:lifeskim |
pubmed-article:20061026 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
pubmed-article:20061026 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:20061026 | lifeskim:mentions | umls-concept:C0162388 | lld:lifeskim |
pubmed-article:20061026 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
pubmed-article:20061026 | lifeskim:mentions | umls-concept:C1522673 | lld:lifeskim |
pubmed-article:20061026 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:20061026 | pubmed:dateCreated | 2010-2-17 | lld:pubmed |
pubmed-article:20061026 | pubmed:abstractText | The aim of this study was to evaluate, in terms of dog macrophage killing ability in vitro, a vaccine based on Leishmania infantum promastigote soluble antigen (LSA) formulated with three different adjuvants (BCG, AdjuPrime, MPL/TDM/CWS). A significant increase of the macrophage killing ability was observed in dogs vaccinated with LSA+MPL/TDM/CWS after 1 month from vaccination. A similar increase of macrophage parasitocidal ability was present only after 5 months in dogs vaccinated with LSA+BCG or LSA+AdjuPrime. In all dogs the augmented killing percentage was still present after 12 months from vaccination. Therefore, in particular LSA+MPL/TDM/CWS vaccine seems promising for further studies in dogs. | lld:pubmed |
pubmed-article:20061026 | pubmed:language | eng | lld:pubmed |
pubmed-article:20061026 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20061026 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20061026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20061026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20061026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20061026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20061026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20061026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20061026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20061026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20061026 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20061026 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20061026 | pubmed:month | Mar | lld:pubmed |
pubmed-article:20061026 | pubmed:issn | 1878-1667 | lld:pubmed |
pubmed-article:20061026 | pubmed:author | pubmed-author:BrandonisioOO | lld:pubmed |
pubmed-article:20061026 | pubmed:author | pubmed-author:MitoloVV | lld:pubmed |
pubmed-article:20061026 | pubmed:author | pubmed-author:GradoniLL | lld:pubmed |
pubmed-article:20061026 | pubmed:author | pubmed-author:AcquafreddaAA | lld:pubmed |
pubmed-article:20061026 | pubmed:author | pubmed-author:FasanellaAA | lld:pubmed |
pubmed-article:20061026 | pubmed:author | pubmed-author:PanaroM AMA | lld:pubmed |
pubmed-article:20061026 | pubmed:author | pubmed-author:TrottaTT | lld:pubmed |
pubmed-article:20061026 | pubmed:author | pubmed-author:ScaltritoDD | lld:pubmed |
pubmed-article:20061026 | pubmed:copyrightInfo | 2009 Elsevier Ltd. All rights reserved. | lld:pubmed |
pubmed-article:20061026 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20061026 | pubmed:volume | 33 | lld:pubmed |
pubmed-article:20061026 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20061026 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20061026 | pubmed:pagination | 175-82 | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:meshHeading | pubmed-meshheading:20061026... | lld:pubmed |
pubmed-article:20061026 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20061026 | pubmed:articleTitle | Comparison between three adjuvants for a vaccine against canine leishmaniasis: In vitro evaluation of macrophage killing ability. | lld:pubmed |
pubmed-article:20061026 | pubmed:affiliation | Dipartimento di Scienze Biomediche, University of Foggia, Ospedali Riuniti, Italy. t.trotta@unifg.it | lld:pubmed |
pubmed-article:20061026 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20061026 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:20061026 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:20061026 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |